The name of this superfamily has been modified since the most recent official CATH+ release (v4_3_0). At the point of the last release, this superfamily was: waiting to be named.
FunFam 22: protein deglycase DJ-1
Please note: GO annotations are assigned to the full protein sequence rather than individual protein domains. Since a given protein can contain multiple domains, it is possible that some of the annotations below come from additional domains that occur in the same protein, but have been classified elsewhere in CATH.
There are 78 GO terms relating to "molecular function"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Protein binding GO:0005515
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
|
13 |
O88767 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
(3 more) |
MRNA binding GO:0003729
Interacting selectively and non-covalently with messenger RNA (mRNA), an intermediate molecule between DNA and protein. mRNA includes UTR and coding sequences, but does not contain introns.
|
12 |
O88767 (/ISS)
Q5E946 (/ISS)
Q5E946 (/ISS)
Q5XJ36 (/ISS)
Q7TQ35 (/ISS)
Q7TQ35 (/ISS)
Q8UW59 (/ISS)
Q95LI9 (/ISS)
Q95LI9 (/ISS)
Q95LI9 (/ISS)
(2 more) |
Peptidase activity GO:0008233
Catalysis of the hydrolysis of a peptide bond. A peptide bond is a covalent bond formed when the carbon atom from the carboxyl group of one amino acid shares electrons with the nitrogen atom from the amino group of a second amino acid.
|
12 |
O88767 (/ISS)
Q5E946 (/ISS)
Q5E946 (/ISS)
Q5XJ36 (/ISS)
Q7TQ35 (/ISS)
Q7TQ35 (/ISS)
Q8UW59 (/ISS)
Q95LI9 (/ISS)
Q95LI9 (/ISS)
Q95LI9 (/ISS)
(2 more) |
Protein homodimerization activity GO:0042803
Interacting selectively and non-covalently with an identical protein to form a homodimer.
|
12 |
O88767 (/ISS)
Q5E946 (/ISS)
Q5E946 (/ISS)
Q5XJ36 (/ISS)
Q7TQ35 (/ISS)
Q7TQ35 (/ISS)
Q8UW59 (/ISS)
Q95LI9 (/ISS)
Q95LI9 (/ISS)
Q95LI9 (/ISS)
(2 more) |
Transcription coactivator activity GO:0003713
A protein or a member of a complex that interacts specifically and non-covalently with a DNA-bound DNA-binding transcription factor to activate the transcription of specific genes. Coactivators often act by altering chromatin structure and modifications. For example, one class of transcription coregulators modifies chromatin structure through covalent modification of histones. A second ATP-dependent class modifies the conformation of chromatin. Another type of coregulator activity is the bridging of a DNA-binding transcription factor to the basal transcription machinery. The Mediator complex, which bridges transcription factors and RNA polymerase, is also a transcription coactivator.
|
11 |
Q99497 (/IGI)
Q99497 (/IGI)
Q99497 (/IGI)
Q99497 (/IGI)
Q99497 (/IGI)
Q99497 (/IGI)
Q99497 (/IGI)
Q99497 (/IGI)
Q99497 (/IGI)
Q99497 (/IGI)
(1 more) |
Transcription coactivator activity GO:0003713
A protein or a member of a complex that interacts specifically and non-covalently with a DNA-bound DNA-binding transcription factor to activate the transcription of specific genes. Coactivators often act by altering chromatin structure and modifications. For example, one class of transcription coregulators modifies chromatin structure through covalent modification of histones. A second ATP-dependent class modifies the conformation of chromatin. Another type of coregulator activity is the bridging of a DNA-binding transcription factor to the basal transcription machinery. The Mediator complex, which bridges transcription factors and RNA polymerase, is also a transcription coactivator.
|
11 |
Q99497 (/TAS)
Q99497 (/TAS)
Q99497 (/TAS)
Q99497 (/TAS)
Q99497 (/TAS)
Q99497 (/TAS)
Q99497 (/TAS)
Q99497 (/TAS)
Q99497 (/TAS)
Q99497 (/TAS)
(1 more) |
MRNA binding GO:0003729
Interacting selectively and non-covalently with messenger RNA (mRNA), an intermediate molecule between DNA and protein. mRNA includes UTR and coding sequences, but does not contain introns.
|
11 |
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
(1 more) |
Signaling receptor binding GO:0005102
Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
|
11 |
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
(1 more) |
Copper ion binding GO:0005507
Interacting selectively and non-covalently with copper (Cu) ions.
|
11 |
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
(1 more) |
Transcription factor binding GO:0008134
Interacting selectively and non-covalently with a transcription factor, a protein required to initiate or regulate transcription.
|
11 |
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
(1 more) |
Peptidase activity GO:0008233
Catalysis of the hydrolysis of a peptide bond. A peptide bond is a covalent bond formed when the carbon atom from the carboxyl group of one amino acid shares electrons with the nitrogen atom from the amino group of a second amino acid.
|
11 |
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
(1 more) |
Superoxide dismutase copper chaperone activity GO:0016532
A copper chaperone activity that specifically delivers copper to the Cu-Zn superoxide dismutase, to activate superoxide dismutase activity.
|
11 |
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
(1 more) |
Oxidoreductase activity, acting on peroxide as acceptor GO:0016684
Catalysis of an oxidation-reduction (redox) reaction in which the peroxide group acts as a hydrogen or electron acceptor.
|
11 |
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
(1 more) |
Enzyme binding GO:0019899
Interacting selectively and non-covalently with any enzyme.
|
11 |
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
(1 more) |
Kinase binding GO:0019900
Interacting selectively and non-covalently with a kinase, any enzyme that catalyzes the transfer of a phosphate group.
|
11 |
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
(1 more) |
Cytokine binding GO:0019955
Interacting selectively and non-covalently with a cytokine, any of a group of proteins that function to control the survival, growth and differentiation of tissues and cells, and which have autocrine and paracrine activity.
|
11 |
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
(1 more) |
Tyrosine 3-monooxygenase activator activity GO:0036470
Interacts with and increases tyrosine 3-monooxygenase (tyrosine hydroxylase) activity.
|
11 |
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
(1 more) |
L-dopa decarboxylase activator activity GO:0036478
Interacts with and increases L-dopa decarboxylase activity.
|
11 |
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
(1 more) |
Protein deglycase activity GO:0036524
Catalysis of the removal of a sugar or dicarbonyl from a lysine residue of a glycated protein.
|
11 |
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
(1 more) |
Identical protein binding GO:0042802
Interacting selectively and non-covalently with an identical protein or proteins.
|
11 |
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
(1 more) |
Protein homodimerization activity GO:0042803
Interacting selectively and non-covalently with an identical protein to form a homodimer.
|
11 |
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
(1 more) |
Small protein activating enzyme binding GO:0044388
Interacting selectively and non-covalently with a small protein activating enzyme, such as ubiquitin-activating enzyme.
|
11 |
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
(1 more) |
Ubiquitin-like protein conjugating enzyme binding GO:0044390
Interacting selectively and non-covalently with a ubiquitin-like protein conjugating enzyme such as ubiquitin conjugating enzyme.
|
11 |
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
(1 more) |
Protein-containing complex binding GO:0044877
Interacting selectively and non-covalently with a macromolecular complex.
|
11 |
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
(1 more) |
Cadherin binding GO:0045296
Interacting selectively and non-covalently with cadherin, a type I membrane protein involved in cell adhesion.
|
11 |
Q99497 (/HDA)
Q99497 (/HDA)
Q99497 (/HDA)
Q99497 (/HDA)
Q99497 (/HDA)
Q99497 (/HDA)
Q99497 (/HDA)
Q99497 (/HDA)
Q99497 (/HDA)
Q99497 (/HDA)
(1 more) |
Mercury ion binding GO:0045340
Interacting selectively and non-covalently with mercury (Hg) ions.
|
11 |
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
(1 more) |
Androgen receptor binding GO:0050681
Interacting selectively and non-covalently with an androgen receptor.
|
11 |
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
(1 more) |
Repressing transcription factor binding GO:0070491
Interacting selectively and non-covalently with a transcription repressor, any protein whose activity is required to prevent or downregulate transcription.
|
11 |
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
(1 more) |
Scaffold protein binding GO:0097110
Interacting selectively and non-covalently with a scaffold protein. Scaffold proteins are crucial regulators of many key signaling pathways. Although not strictly defined in function, they are known to interact and/or bind with multiple members of a signaling pathway, tethering them into complexes.
|
11 |
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
(1 more) |
Cupric ion binding GO:1903135
Interacting selectively and non-covalently with cupric ion, copper(2+).
|
11 |
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
(1 more) |
Cuprous ion binding GO:1903136
Interacting selectively and non-covalently with cuprous ion, copper(1+).
|
11 |
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
(1 more) |
Ubiquitin-specific protease binding GO:1990381
Interacting selectively and non-covalently with a ubiquitin-specific protease.
|
11 |
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
Q99497 (/IPI)
(1 more) |
Copper ion binding GO:0005507
Interacting selectively and non-covalently with copper (Cu) ions.
|
10 | O88767 (/ISS) Q5E946 (/ISS) Q5E946 (/ISS) Q7TQ35 (/ISS) Q7TQ35 (/ISS) Q95LI9 (/ISS) Q95LI9 (/ISS) Q95LI9 (/ISS) Q95LI9 (/ISS) Q99LX0 (/ISS) |
Mercury ion binding GO:0045340
Interacting selectively and non-covalently with mercury (Hg) ions.
|
10 | O88767 (/ISS) Q5E946 (/ISS) Q5E946 (/ISS) Q7TQ35 (/ISS) Q7TQ35 (/ISS) Q95LI9 (/ISS) Q95LI9 (/ISS) Q95LI9 (/ISS) Q95LI9 (/ISS) Q99LX0 (/ISS) |
Oxidoreductase activity, acting on peroxide as acceptor GO:0016684
Catalysis of an oxidation-reduction (redox) reaction in which the peroxide group acts as a hydrogen or electron acceptor.
|
2 | A1Z9J4 (/ISS) Q9VA37 (/ISS) |
Protein deglycase activity GO:0036524
Catalysis of the removal of a sugar or dicarbonyl from a lysine residue of a glycated protein.
|
2 | A1Z9J4 (/ISS) Q9VA37 (/ISS) |
Transcription coactivator activity GO:0003713
A protein or a member of a complex that interacts specifically and non-covalently with a DNA-bound DNA-binding transcription factor to activate the transcription of specific genes. Coactivators often act by altering chromatin structure and modifications. For example, one class of transcription coregulators modifies chromatin structure through covalent modification of histones. A second ATP-dependent class modifies the conformation of chromatin. Another type of coregulator activity is the bridging of a DNA-binding transcription factor to the basal transcription machinery. The Mediator complex, which bridges transcription factors and RNA polymerase, is also a transcription coactivator.
|
1 | Q99LX0 (/ISO) |
Transcription coactivator activity GO:0003713
A protein or a member of a complex that interacts specifically and non-covalently with a DNA-bound DNA-binding transcription factor to activate the transcription of specific genes. Coactivators often act by altering chromatin structure and modifications. For example, one class of transcription coregulators modifies chromatin structure through covalent modification of histones. A second ATP-dependent class modifies the conformation of chromatin. Another type of coregulator activity is the bridging of a DNA-binding transcription factor to the basal transcription machinery. The Mediator complex, which bridges transcription factors and RNA polymerase, is also a transcription coactivator.
|
1 | O88767 (/ISS) |
RNA binding GO:0003723
Interacting selectively and non-covalently with an RNA molecule or a portion thereof.
|
1 | Q99LX0 (/TAS) |
MRNA binding GO:0003729
Interacting selectively and non-covalently with messenger RNA (mRNA), an intermediate molecule between DNA and protein. mRNA includes UTR and coding sequences, but does not contain introns.
|
1 | Q99LX0 (/ISO) |
Signaling receptor binding GO:0005102
Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
|
1 | Q99LX0 (/ISO) |
Signaling receptor binding GO:0005102
Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
|
1 | O88767 (/ISS) |
Copper ion binding GO:0005507
Interacting selectively and non-covalently with copper (Cu) ions.
|
1 | Q99LX0 (/ISO) |
Transcription factor binding GO:0008134
Interacting selectively and non-covalently with a transcription factor, a protein required to initiate or regulate transcription.
|
1 | Q99LX0 (/ISO) |
Transcription factor binding GO:0008134
Interacting selectively and non-covalently with a transcription factor, a protein required to initiate or regulate transcription.
|
1 | O88767 (/ISS) |
Peptidase activity GO:0008233
Catalysis of the hydrolysis of a peptide bond. A peptide bond is a covalent bond formed when the carbon atom from the carboxyl group of one amino acid shares electrons with the nitrogen atom from the amino group of a second amino acid.
|
1 | Q99LX0 (/ISO) |
Superoxide dismutase copper chaperone activity GO:0016532
A copper chaperone activity that specifically delivers copper to the Cu-Zn superoxide dismutase, to activate superoxide dismutase activity.
|
1 | Q99LX0 (/ISO) |
Superoxide dismutase copper chaperone activity GO:0016532
A copper chaperone activity that specifically delivers copper to the Cu-Zn superoxide dismutase, to activate superoxide dismutase activity.
|
1 | O88767 (/ISS) |
Oxidoreductase activity, acting on peroxide as acceptor GO:0016684
Catalysis of an oxidation-reduction (redox) reaction in which the peroxide group acts as a hydrogen or electron acceptor.
|
1 | Q99LX0 (/ISO) |
Enzyme binding GO:0019899
Interacting selectively and non-covalently with any enzyme.
|
1 | Q99LX0 (/ISO) |
Kinase binding GO:0019900
Interacting selectively and non-covalently with a kinase, any enzyme that catalyzes the transfer of a phosphate group.
|
1 | Q99LX0 (/ISO) |
Cytokine binding GO:0019955
Interacting selectively and non-covalently with a cytokine, any of a group of proteins that function to control the survival, growth and differentiation of tissues and cells, and which have autocrine and paracrine activity.
|
1 | Q99LX0 (/ISO) |
Cytokine binding GO:0019955
Interacting selectively and non-covalently with a cytokine, any of a group of proteins that function to control the survival, growth and differentiation of tissues and cells, and which have autocrine and paracrine activity.
|
1 | O88767 (/ISS) |
Tyrosine 3-monooxygenase activator activity GO:0036470
Interacts with and increases tyrosine 3-monooxygenase (tyrosine hydroxylase) activity.
|
1 | Q99LX0 (/ISO) |
Tyrosine 3-monooxygenase activator activity GO:0036470
Interacts with and increases tyrosine 3-monooxygenase (tyrosine hydroxylase) activity.
|
1 | O88767 (/ISS) |
L-dopa decarboxylase activator activity GO:0036478
Interacts with and increases L-dopa decarboxylase activity.
|
1 | Q99LX0 (/ISO) |
L-dopa decarboxylase activator activity GO:0036478
Interacts with and increases L-dopa decarboxylase activity.
|
1 | O88767 (/ISS) |
Protein deglycase activity GO:0036524
Catalysis of the removal of a sugar or dicarbonyl from a lysine residue of a glycated protein.
|
1 | Q99LX0 (/ISO) |
Identical protein binding GO:0042802
Interacting selectively and non-covalently with an identical protein or proteins.
|
1 | Q99LX0 (/ISO) |
Protein homodimerization activity GO:0042803
Interacting selectively and non-covalently with an identical protein to form a homodimer.
|
1 | Q99LX0 (/ISO) |
Small protein activating enzyme binding GO:0044388
Interacting selectively and non-covalently with a small protein activating enzyme, such as ubiquitin-activating enzyme.
|
1 | Q99LX0 (/ISO) |
Small protein activating enzyme binding GO:0044388
Interacting selectively and non-covalently with a small protein activating enzyme, such as ubiquitin-activating enzyme.
|
1 | O88767 (/ISS) |
Ubiquitin-like protein conjugating enzyme binding GO:0044390
Interacting selectively and non-covalently with a ubiquitin-like protein conjugating enzyme such as ubiquitin conjugating enzyme.
|
1 | Q99LX0 (/ISO) |
Ubiquitin-like protein conjugating enzyme binding GO:0044390
Interacting selectively and non-covalently with a ubiquitin-like protein conjugating enzyme such as ubiquitin conjugating enzyme.
|
1 | O88767 (/ISS) |
Protein-containing complex binding GO:0044877
Interacting selectively and non-covalently with a macromolecular complex.
|
1 | Q99LX0 (/ISO) |
Mercury ion binding GO:0045340
Interacting selectively and non-covalently with mercury (Hg) ions.
|
1 | Q99LX0 (/ISO) |
Androgen receptor binding GO:0050681
Interacting selectively and non-covalently with an androgen receptor.
|
1 | Q99LX0 (/ISO) |
Androgen receptor binding GO:0050681
Interacting selectively and non-covalently with an androgen receptor.
|
1 | O88767 (/ISS) |
Peroxiredoxin activity GO:0051920
Catalysis of the reaction: 2 R'-SH + ROOH = R'-S-S-R' + H2O + ROH.
|
1 | Q99LX0 (/IMP) |
Repressing transcription factor binding GO:0070491
Interacting selectively and non-covalently with a transcription repressor, any protein whose activity is required to prevent or downregulate transcription.
|
1 | Q99LX0 (/ISO) |
Repressing transcription factor binding GO:0070491
Interacting selectively and non-covalently with a transcription repressor, any protein whose activity is required to prevent or downregulate transcription.
|
1 | O88767 (/ISS) |
Scaffold protein binding GO:0097110
Interacting selectively and non-covalently with a scaffold protein. Scaffold proteins are crucial regulators of many key signaling pathways. Although not strictly defined in function, they are known to interact and/or bind with multiple members of a signaling pathway, tethering them into complexes.
|
1 | Q99LX0 (/ISO) |
Scaffold protein binding GO:0097110
Interacting selectively and non-covalently with a scaffold protein. Scaffold proteins are crucial regulators of many key signaling pathways. Although not strictly defined in function, they are known to interact and/or bind with multiple members of a signaling pathway, tethering them into complexes.
|
1 | O88767 (/ISS) |
Cupric ion binding GO:1903135
Interacting selectively and non-covalently with cupric ion, copper(2+).
|
1 | Q99LX0 (/ISO) |
Cupric ion binding GO:1903135
Interacting selectively and non-covalently with cupric ion, copper(2+).
|
1 | O88767 (/ISS) |
Cuprous ion binding GO:1903136
Interacting selectively and non-covalently with cuprous ion, copper(1+).
|
1 | Q99LX0 (/ISO) |
Cuprous ion binding GO:1903136
Interacting selectively and non-covalently with cuprous ion, copper(1+).
|
1 | O88767 (/ISS) |
Ubiquitin-specific protease binding GO:1990381
Interacting selectively and non-covalently with a ubiquitin-specific protease.
|
1 | Q99LX0 (/ISO) |
There are 266 GO terms relating to "biological process"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Insulin secretion GO:0030073
The regulated release of proinsulin from secretory granules accompanied by cleavage of proinsulin to form mature insulin. In vertebrates, insulin is secreted from B granules in the B cells of the vertebrate pancreas and from insulin-producing cells in insects.
|
22 |
O88767 (/ISS)
Q5E946 (/ISS)
Q5E946 (/ISS)
Q5XJ36 (/ISS)
Q7TQ35 (/ISS)
Q7TQ35 (/ISS)
Q8UW59 (/ISS)
Q95LI9 (/ISS)
Q95LI9 (/ISS)
Q95LI9 (/ISS)
(12 more) |
Glucose homeostasis GO:0042593
Any process involved in the maintenance of an internal steady state of glucose within an organism or cell.
|
22 |
O88767 (/ISS)
Q5E946 (/ISS)
Q5E946 (/ISS)
Q5XJ36 (/ISS)
Q7TQ35 (/ISS)
Q7TQ35 (/ISS)
Q8UW59 (/ISS)
Q95LI9 (/ISS)
Q95LI9 (/ISS)
Q95LI9 (/ISS)
(12 more) |
Negative regulation of reactive oxygen species biosynthetic process GO:1903427
Any process that stops, prevents or reduces the frequency, rate or extent of reactive oxygen species biosynthetic process.
|
22 |
O88767 (/ISS)
Q5E946 (/ISS)
Q5E946 (/ISS)
Q5XJ36 (/ISS)
Q7TQ35 (/ISS)
Q7TQ35 (/ISS)
Q8UW59 (/ISS)
Q95LI9 (/ISS)
Q95LI9 (/ISS)
Q95LI9 (/ISS)
(12 more) |
Positive regulation of acute inflammatory response to antigenic stimulus GO:0002866
Any process that activates or increases the frequency, rate, or extent of an acute inflammatory response to an antigenic stimulus.
|
21 |
O88767 (/ISS)
Q5E946 (/ISS)
Q5E946 (/ISS)
Q7TQ35 (/ISS)
Q7TQ35 (/ISS)
Q8UW59 (/ISS)
Q95LI9 (/ISS)
Q95LI9 (/ISS)
Q95LI9 (/ISS)
Q95LI9 (/ISS)
(11 more) |
Positive regulation of NAD(P)H oxidase activity GO:0033864
Any process that activates or increases the activity of the enzyme NAD(P)H oxidase.
|
21 |
O88767 (/ISS)
Q5E946 (/ISS)
Q5E946 (/ISS)
Q7TQ35 (/ISS)
Q7TQ35 (/ISS)
Q8UW59 (/ISS)
Q95LI9 (/ISS)
Q95LI9 (/ISS)
Q95LI9 (/ISS)
Q95LI9 (/ISS)
(11 more) |
Mitochondrion organization GO:0007005
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a mitochondrion; includes mitochondrial morphogenesis and distribution, and replication of the mitochondrial genome as well as synthesis of new mitochondrial components.
|
20 |
O88767 (/ISS)
Q5E946 (/ISS)
Q5E946 (/ISS)
Q7TQ35 (/ISS)
Q7TQ35 (/ISS)
Q95LI9 (/ISS)
Q95LI9 (/ISS)
Q95LI9 (/ISS)
Q95LI9 (/ISS)
Q99497 (/ISS)
(10 more) |
Regulation of inflammatory response GO:0050727
Any process that modulates the frequency, rate or extent of the inflammatory response, the immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents.
|
20 |
O88767 (/ISS)
Q5E946 (/ISS)
Q5E946 (/ISS)
Q7TQ35 (/ISS)
Q7TQ35 (/ISS)
Q95LI9 (/ISS)
Q95LI9 (/ISS)
Q95LI9 (/ISS)
Q95LI9 (/ISS)
Q99497 (/ISS)
(10 more) |
Glycolate biosynthetic process GO:0046295
The chemical reactions and pathways resulting in the formation of glycolate, the anion of hydroxyethanoic acid (glycolic acid).
|
14 |
O16228 (/IDA)
P90994 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
(4 more) |
Glyoxal metabolic process GO:1903189
The chemical reactions and pathways involving glyoxal.
|
14 |
O16228 (/IDA)
P90994 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
(4 more) |
Methylglyoxal metabolic process GO:0009438
The chemical reactions and pathways involving methylglyoxal, CH3-CO-CHO, the aldehyde of pyruvic acid.
|
13 |
O16228 (/IDA)
P90994 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
(3 more) |
Lactate biosynthetic process GO:0019249
The chemical reactions and pathways resulting in the formation of lactate, the anion of lactic acid.
|
13 |
O16228 (/IDA)
P90994 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
(3 more) |
Cellular response to glyoxal GO:0036471
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glyoxal stimulus.
|
13 |
O16228 (/IDA)
P90994 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
(3 more) |
DNA repair GO:0006281
The process of restoring DNA after damage. Genomes are subject to damage by chemical and physical agents in the environment (e.g. UV and ionizing radiations, chemical mutagens, fungal and bacterial toxins, etc.) and by free radicals or alkylating agents endogenously generated in metabolism. DNA is also damaged because of errors during its replication. A variety of different DNA repair pathways have been reported that include direct reversal, base excision repair, nucleotide excision repair, photoreactivation, bypass, double-strand break repair pathway, and mismatch repair pathway.
|
12 |
O88767 (/ISS)
Q5E946 (/ISS)
Q5E946 (/ISS)
Q5XJ36 (/ISS)
Q7TQ35 (/ISS)
Q7TQ35 (/ISS)
Q8UW59 (/ISS)
Q95LI9 (/ISS)
Q95LI9 (/ISS)
Q95LI9 (/ISS)
(2 more) |
Protein deglycosylation GO:0006517
The removal of sugar residues from a glycosylated protein.
|
12 |
O88767 (/ISS)
Q5E946 (/ISS)
Q5E946 (/ISS)
Q5XJ36 (/ISS)
Q7TQ35 (/ISS)
Q7TQ35 (/ISS)
Q8UW59 (/ISS)
Q95LI9 (/ISS)
Q95LI9 (/ISS)
Q95LI9 (/ISS)
(2 more) |
Detoxification of copper ion GO:0010273
Any process that reduces or removes the toxicity of copper ion. These include transport of copper away from sensitive areas and to compartments or complexes whose purpose is sequestration of copper ion.
|
12 |
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
(2 more) |
Cellular response to oxidative stress GO:0034599
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of oxidative stress, a state often resulting from exposure to high levels of reactive oxygen species, e.g. superoxide anions, hydrogen peroxide (H2O2), and hydroxyl radicals.
|
12 |
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
(2 more) |
Regulation of neuron apoptotic process GO:0043523
Any process that modulates the occurrence or rate of cell death by apoptotic process in neurons.
|
12 |
O88767 (/ISS)
Q5E946 (/ISS)
Q5E946 (/ISS)
Q5XJ36 (/ISS)
Q7TQ35 (/ISS)
Q7TQ35 (/ISS)
Q8UW59 (/ISS)
Q95LI9 (/ISS)
Q95LI9 (/ISS)
Q95LI9 (/ISS)
(2 more) |
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
|
12 |
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
(2 more) |
Detoxification of mercury ion GO:0050787
Any process that reduce or remove the toxicity of mercuric ion. These include transport of mercury away from sensitive areas and to compartments or complexes whose purpose is sequestration of mercury ion and/or reduction of mercury ion (Hg
|
12 |
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
(2 more) |
Protein stabilization GO:0050821
Any process involved in maintaining the structure and integrity of a protein and preventing it from degradation or aggregation.
|
12 |
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
(2 more) |
Protein stabilization GO:0050821
Any process involved in maintaining the structure and integrity of a protein and preventing it from degradation or aggregation.
|
12 |
O88767 (/ISS)
Q5E946 (/ISS)
Q5E946 (/ISS)
Q5XJ36 (/ISS)
Q7TQ35 (/ISS)
Q7TQ35 (/ISS)
Q8UW59 (/ISS)
Q95LI9 (/ISS)
Q95LI9 (/ISS)
Q95LI9 (/ISS)
(2 more) |
Guanine deglycation GO:0106044
The removal of a sugar or dicarbonyl from a glycated guanine.
|
12 |
O88767 (/ISS)
Q5E946 (/ISS)
Q5E946 (/ISS)
Q5XJ36 (/ISS)
Q7TQ35 (/ISS)
Q7TQ35 (/ISS)
Q8UW59 (/ISS)
Q95LI9 (/ISS)
Q95LI9 (/ISS)
Q95LI9 (/ISS)
(2 more) |
Guanine deglycation, methylglyoxal removal GO:0106045
The removal of methylglyoxal from a glycated guanine, to form lactate and a deglycated guanine.
|
12 |
O88767 (/ISS)
Q5E946 (/ISS)
Q5E946 (/ISS)
Q5XJ36 (/ISS)
Q7TQ35 (/ISS)
Q7TQ35 (/ISS)
Q8UW59 (/ISS)
Q95LI9 (/ISS)
Q95LI9 (/ISS)
Q95LI9 (/ISS)
(2 more) |
Guanine deglycation, glyoxal removal GO:0106046
The removal of glyoxal from a glycated guanine, to form glycolate and a deglycated guanine.
|
12 |
O88767 (/ISS)
Q5E946 (/ISS)
Q5E946 (/ISS)
Q5XJ36 (/ISS)
Q7TQ35 (/ISS)
Q7TQ35 (/ISS)
Q8UW59 (/ISS)
Q95LI9 (/ISS)
Q95LI9 (/ISS)
Q95LI9 (/ISS)
(2 more) |
Positive regulation of mitochondrial electron transport, NADH to ubiquinone GO:1902958
Any process that activates or increases the frequency, rate or extent of mitochondrial electron transport, NADH to ubiquinone.
|
12 |
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
(2 more) |
Negative regulation of protein phosphorylation GO:0001933
Any process that stops, prevents or reduces the rate of addition of phosphate groups to amino acids within a protein.
|
11 |
Q99497 (/IGI)
Q99497 (/IGI)
Q99497 (/IGI)
Q99497 (/IGI)
Q99497 (/IGI)
Q99497 (/IGI)
Q99497 (/IGI)
Q99497 (/IGI)
Q99497 (/IGI)
Q99497 (/IGI)
(1 more) |
DNA repair GO:0006281
The process of restoring DNA after damage. Genomes are subject to damage by chemical and physical agents in the environment (e.g. UV and ionizing radiations, chemical mutagens, fungal and bacterial toxins, etc.) and by free radicals or alkylating agents endogenously generated in metabolism. DNA is also damaged because of errors during its replication. A variety of different DNA repair pathways have been reported that include direct reversal, base excision repair, nucleotide excision repair, photoreactivation, bypass, double-strand break repair pathway, and mismatch repair pathway.
|
11 |
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
(1 more) |
Negative regulation of protein kinase activity GO:0006469
Any process that stops, prevents, or reduces the frequency, rate or extent of protein kinase activity.
|
11 |
Q99497 (/IGI)
Q99497 (/IGI)
Q99497 (/IGI)
Q99497 (/IGI)
Q99497 (/IGI)
Q99497 (/IGI)
Q99497 (/IGI)
Q99497 (/IGI)
Q99497 (/IGI)
Q99497 (/IGI)
(1 more) |
Protein deglycosylation GO:0006517
The removal of sugar residues from a glycosylated protein.
|
11 |
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
(1 more) |
Protein deglycosylation GO:0006517
The removal of sugar residues from a glycosylated protein.
|
11 |
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
(1 more) |
Ras protein signal transduction GO:0007265
A series of molecular signals within the cell that are mediated by a member of the Ras superfamily of proteins switching to a GTP-bound active state.
|
11 |
Q99497 (/TAS)
Q99497 (/TAS)
Q99497 (/TAS)
Q99497 (/TAS)
Q99497 (/TAS)
Q99497 (/TAS)
Q99497 (/TAS)
Q99497 (/TAS)
Q99497 (/TAS)
Q99497 (/TAS)
(1 more) |
Positive regulation of gene expression GO:0010628
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
11 |
Q99497 (/TAS)
Q99497 (/TAS)
Q99497 (/TAS)
Q99497 (/TAS)
Q99497 (/TAS)
Q99497 (/TAS)
Q99497 (/TAS)
Q99497 (/TAS)
Q99497 (/TAS)
Q99497 (/TAS)
(1 more) |
Negative regulation of gene expression GO:0010629
Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
11 |
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
(1 more) |
Negative regulation of protein ubiquitination GO:0031397
Any process that stops, prevents, or reduces the frequency, rate or extent of the addition of ubiquitin groups to a protein.
|
11 |
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
(1 more) |
Negative regulation of protein binding GO:0032091
Any process that stops, prevents, or reduces the frequency, rate or extent of protein binding.
|
11 |
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
(1 more) |
Negative regulation of protein binding GO:0032091
Any process that stops, prevents, or reduces the frequency, rate or extent of protein binding.
|
11 |
Q99497 (/IGI)
Q99497 (/IGI)
Q99497 (/IGI)
Q99497 (/IGI)
Q99497 (/IGI)
Q99497 (/IGI)
Q99497 (/IGI)
Q99497 (/IGI)
Q99497 (/IGI)
Q99497 (/IGI)
(1 more) |
Negative regulation of protein binding GO:0032091
Any process that stops, prevents, or reduces the frequency, rate or extent of protein binding.
|
11 |
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
(1 more) |
Activation of protein kinase B activity GO:0032148
Any process that initiates the activity of the inactive enzyme protein kinase B.
|
11 |
Q99497 (/IC)
Q99497 (/IC)
Q99497 (/IC)
Q99497 (/IC)
Q99497 (/IC)
Q99497 (/IC)
Q99497 (/IC)
Q99497 (/IC)
Q99497 (/IC)
Q99497 (/IC)
(1 more) |
Negative regulation of proteasomal ubiquitin-dependent protein catabolic process GO:0032435
Any process that stops, prevents, or reduces the frequency, rate or extent of the breakdown of a protein or peptide by hydrolysis of its peptide bonds, initiated by the covalent attachment of ubiquitin, and mediated by the proteasome.
|
11 |
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
(1 more) |
Positive regulation of interleukin-8 production GO:0032757
Any process that activates or increases the frequency, rate, or extent of interleukin-8 production.
|
11 |
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
(1 more) |
Positive regulation of peptidyl-serine phosphorylation GO:0033138
Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-serine.
|
11 |
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
(1 more) |
Negative regulation of protein sumoylation GO:0033234
Any process that stops, prevents, or reduces the frequency, rate or extent of the addition of SUMO groups to a protein.
|
11 |
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
(1 more) |
Cellular response to oxidative stress GO:0034599
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of oxidative stress, a state often resulting from exposure to high levels of reactive oxygen species, e.g. superoxide anions, hydrogen peroxide (H2O2), and hydroxyl radicals.
|
11 |
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
(1 more) |
Cellular response to oxidative stress GO:0034599
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of oxidative stress, a state often resulting from exposure to high levels of reactive oxygen species, e.g. superoxide anions, hydrogen peroxide (H2O2), and hydroxyl radicals.
|
11 |
O88767 (/ISS)
Q5E946 (/ISS)
Q5E946 (/ISS)
Q5XJ36 (/ISS)
Q7TQ35 (/ISS)
Q7TQ35 (/ISS)
Q8UW59 (/ISS)
Q95LI9 (/ISS)
Q95LI9 (/ISS)
Q95LI9 (/ISS)
(1 more) |
Peptidyl-cysteine deglycation GO:0036526
The removal of a sugar or dicarbonyl from a cysteine residue of a glycated protein.
|
11 |
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
(1 more) |
Peptidyl-arginine deglycation GO:0036527
The removal of a sugar or dicarbonyl from an arginine residue of a glycated protein.
|
11 |
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
(1 more) |
Peptidyl-lysine deglycation GO:0036528
The removal of a sugar or dicarbonyl from a lysine residue of a glycated protein.
|
11 |
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
(1 more) |
Protein deglycation, glyoxal removal GO:0036529
The removal of glyoxal from a glycated protein, to form glycolate and a deglycated protein.
|
11 |
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
(1 more) |
Protein deglycation, methylglyoxal removal GO:0036530
The removal of methylglyoxal from a glycated protein, to form lactate and a deglycated protein.
|
11 |
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
(1 more) |
Glutathione deglycation GO:0036531
The removal of a sugar or dicarbonyl from glycated glutathione. Glutathione is the tripeptide glutamylcysteinylglycine.
|
11 |
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
(1 more) |
Hydrogen peroxide metabolic process GO:0042743
The chemical reactions and pathways involving hydrogen peroxide (H2O2), a potentially harmful byproduct of aerobic cellular respiration which can cause damage to DNA.
|
11 |
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
(1 more) |
Negative regulation of apoptotic process GO:0043066
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
|
11 |
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
(1 more) |
Regulation of neuron apoptotic process GO:0043523
Any process that modulates the occurrence or rate of cell death by apoptotic process in neurons.
|
11 |
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
(1 more) |
Negative regulation of neuron apoptotic process GO:0043524
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process in neurons.
|
11 |
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
(1 more) |
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
|
11 |
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
(1 more) |
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
|
11 |
Q99497 (/IGI)
Q99497 (/IGI)
Q99497 (/IGI)
Q99497 (/IGI)
Q99497 (/IGI)
Q99497 (/IGI)
Q99497 (/IGI)
Q99497 (/IGI)
Q99497 (/IGI)
Q99497 (/IGI)
(1 more) |
Negative regulation of protein export from nucleus GO:0046826
Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of proteins from the nucleus into the cytoplasm.
|
11 |
Q99497 (/IGI)
Q99497 (/IGI)
Q99497 (/IGI)
Q99497 (/IGI)
Q99497 (/IGI)
Q99497 (/IGI)
Q99497 (/IGI)
Q99497 (/IGI)
Q99497 (/IGI)
Q99497 (/IGI)
(1 more) |
Protein stabilization GO:0050821
Any process involved in maintaining the structure and integrity of a protein and preventing it from degradation or aggregation.
|
11 |
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
(1 more) |
Positive regulation of DNA-binding transcription factor activity GO:0051091
Any process that activates or increases the frequency, rate or extent of activity of a transcription factor, any factor involved in the initiation or regulation of transcription.
|
11 |
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
(1 more) |
Positive regulation of DNA-binding transcription factor activity GO:0051091
Any process that activates or increases the frequency, rate or extent of activity of a transcription factor, any factor involved in the initiation or regulation of transcription.
|
11 |
Q99497 (/TAS)
Q99497 (/TAS)
Q99497 (/TAS)
Q99497 (/TAS)
Q99497 (/TAS)
Q99497 (/TAS)
Q99497 (/TAS)
Q99497 (/TAS)
Q99497 (/TAS)
Q99497 (/TAS)
(1 more) |
Negative regulation of ubiquitin-protein transferase activity GO:0051444
Any process that stops, prevents, or reduces the frequency, rate or extent of ubiquitin transferase activity.
|
11 |
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
(1 more) |
Regulation of mitochondrial membrane potential GO:0051881
Any process that modulates the establishment or extent of the mitochondrial membrane potential, the electric potential existing across the mitochondrial membrane arising from charges in the membrane itself and from the charges present in the media on either side of the membrane.
|
11 |
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
(1 more) |
Positive regulation of protein kinase B signaling GO:0051897
Any process that activates or increases the frequency, rate or extent of protein kinase B signaling, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B.
|
11 |
Q99497 (/IC)
Q99497 (/IC)
Q99497 (/IC)
Q99497 (/IC)
Q99497 (/IC)
Q99497 (/IC)
Q99497 (/IC)
Q99497 (/IC)
Q99497 (/IC)
Q99497 (/IC)
(1 more) |
Negative regulation of cell death GO:0060548
Any process that decreases the rate or frequency of cell death. Cell death is the specific activation or halting of processes within a cell so that its vital functions markedly cease, rather than simply deteriorating gradually over time, which culminates in cell death.
|
11 |
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
(1 more) |
Negative regulation of cell death GO:0060548
Any process that decreases the rate or frequency of cell death. Cell death is the specific activation or halting of processes within a cell so that its vital functions markedly cease, rather than simply deteriorating gradually over time, which culminates in cell death.
|
11 |
O88767 (/ISS)
Q5E946 (/ISS)
Q5E946 (/ISS)
Q5XJ36 (/ISS)
Q7TQ35 (/ISS)
Q7TQ35 (/ISS)
Q8UW59 (/ISS)
Q95LI9 (/ISS)
Q95LI9 (/ISS)
Q95LI9 (/ISS)
(1 more) |
Regulation of androgen receptor signaling pathway GO:0060765
Any process that modulates the rate, frequency, or extent of the androgen receptor signaling pathway.
|
11 |
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
(1 more) |
Cellular response to hydrogen peroxide GO:0070301
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hydrogen peroxide (H2O2) stimulus.
|
11 |
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
(1 more) |
Cellular response to hydrogen peroxide GO:0070301
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hydrogen peroxide (H2O2) stimulus.
|
11 |
O88767 (/ISS)
Q5E946 (/ISS)
Q5E946 (/ISS)
Q5XJ36 (/ISS)
Q7TQ35 (/ISS)
Q7TQ35 (/ISS)
Q8UW59 (/ISS)
Q95LI9 (/ISS)
Q95LI9 (/ISS)
Q95LI9 (/ISS)
(1 more) |
Positive regulation of protein homodimerization activity GO:0090073
Any process that increases the frequency, rate or extent of protein homodimerization, interacting selectively with an identical protein to form a homodimer.
|
11 |
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
(1 more) |
Guanine deglycation GO:0106044
The removal of a sugar or dicarbonyl from a glycated guanine.
|
11 |
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
(1 more) |
Guanine deglycation, methylglyoxal removal GO:0106045
The removal of methylglyoxal from a glycated guanine, to form lactate and a deglycated guanine.
|
11 |
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
(1 more) |
Guanine deglycation, glyoxal removal GO:0106046
The removal of glyoxal from a glycated guanine, to form glycolate and a deglycated guanine.
|
11 |
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
(1 more) |
Positive regulation of protein localization to nucleus GO:1900182
Any process that activates or increases the frequency, rate or extent of protein localization to nucleus.
|
11 |
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
(1 more) |
Positive regulation of protein localization to nucleus GO:1900182
Any process that activates or increases the frequency, rate or extent of protein localization to nucleus.
|
11 |
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
(1 more) |
Negative regulation of neuron death GO:1901215
Any process that stops, prevents or reduces the frequency, rate or extent of neuron death.
|
11 |
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
(1 more) |
Positive regulation of superoxide dismutase activity GO:1901671
Any process that activates or increases the frequency, rate or extent of superoxide dismutase activity.
|
11 |
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
(1 more) |
Negative regulation of protein acetylation GO:1901984
Any process that stops, prevents or reduces the frequency, rate or extent of protein acetylation.
|
11 |
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
(1 more) |
Negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway GO:1902236
Any process that stops, prevents or reduces the frequency, rate or extent of an endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway.
|
11 |
Q99497 (/IGI)
Q99497 (/IGI)
Q99497 (/IGI)
Q99497 (/IGI)
Q99497 (/IGI)
Q99497 (/IGI)
Q99497 (/IGI)
Q99497 (/IGI)
Q99497 (/IGI)
Q99497 (/IGI)
(1 more) |
Regulation of supramolecular fiber organization GO:1902903
Any process that modulates the frequency, rate or extent of supramolecular fiber organization.
|
11 |
Q99497 (/TAS)
Q99497 (/TAS)
Q99497 (/TAS)
Q99497 (/TAS)
Q99497 (/TAS)
Q99497 (/TAS)
Q99497 (/TAS)
Q99497 (/TAS)
Q99497 (/TAS)
Q99497 (/TAS)
(1 more) |
Negative regulation of death-inducing signaling complex assembly GO:1903073
Any process that stops, prevents or reduces the frequency, rate or extent of death-inducing signaling complex assembly.
|
11 |
Q99497 (/IC)
Q99497 (/IC)
Q99497 (/IC)
Q99497 (/IC)
Q99497 (/IC)
Q99497 (/IC)
Q99497 (/IC)
Q99497 (/IC)
Q99497 (/IC)
Q99497 (/IC)
(1 more) |
Negative regulation of protein K48-linked deubiquitination GO:1903094
Any process that stops, prevents or reduces the frequency, rate or extent of protein K48-linked deubiquitination.
|
11 |
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
(1 more) |
Negative regulation of TRAIL-activated apoptotic signaling pathway GO:1903122
Any process that stops, prevents or reduces the frequency, rate or extent of TRAIL-activated apoptotic signaling pathway.
|
11 |
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
(1 more) |
Positive regulation of pyrroline-5-carboxylate reductase activity GO:1903168
Any process that activates or increases the frequency, rate or extent of pyrroline-5-carboxylate reductase activity.
|
11 |
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
(1 more) |
Positive regulation of tyrosine 3-monooxygenase activity GO:1903178
Any process that activates or increases the frequency, rate or extent of tyrosine 3-monooxygenase activity.
|
11 |
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
(1 more) |
Positive regulation of dopamine biosynthetic process GO:1903181
Any process that activates or increases the frequency, rate or extent of dopamine biosynthetic process.
|
11 |
Q99497 (/IC)
Q99497 (/IC)
Q99497 (/IC)
Q99497 (/IC)
Q99497 (/IC)
Q99497 (/IC)
Q99497 (/IC)
Q99497 (/IC)
Q99497 (/IC)
Q99497 (/IC)
(1 more) |
Positive regulation of dopamine biosynthetic process GO:1903181
Any process that activates or increases the frequency, rate or extent of dopamine biosynthetic process.
|
11 |
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
(1 more) |
Positive regulation of L-dopa biosynthetic process GO:1903197
Any process that activates or increases the frequency, rate or extent of L-dopa biosynthetic process.
|
11 |
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
(1 more) |
Positive regulation of L-dopa decarboxylase activity GO:1903200
Any process that activates or increases the frequency, rate or extent of L-dopa decarboxylase activity.
|
11 |
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
(1 more) |
Negative regulation of oxidative stress-induced cell death GO:1903202
Any process that stops, prevents or reduces the frequency, rate or extent of oxidative stress-induced cell death.
|
11 |
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
(1 more) |
Negative regulation of hydrogen peroxide-induced cell death GO:1903206
Any process that stops, prevents or reduces the frequency, rate or extent of hydrogen peroxide-induced cell death.
|
11 |
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
(1 more) |
Negative regulation of hydrogen peroxide-induced neuron death GO:1903208
Any process that stops, prevents or reduces the frequency, rate or extent of hydrogen peroxide-induced neuron death.
|
11 |
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
(1 more) |
Negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway GO:1903377
Any process that stops, prevents or reduces the frequency, rate or extent of oxidative stress-induced neuron intrinsic apoptotic signaling pathway.
|
11 |
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
(1 more) |
Negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway GO:1903384
Any process that stops, prevents or reduces the frequency, rate or extent of a hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway.
|
11 |
Q99497 (/IGI)
Q99497 (/IGI)
Q99497 (/IGI)
Q99497 (/IGI)
Q99497 (/IGI)
Q99497 (/IGI)
Q99497 (/IGI)
Q99497 (/IGI)
Q99497 (/IGI)
Q99497 (/IGI)
(1 more) |
Positive regulation of autophagy of mitochondrion GO:1903599
Any process that activates or increases the frequency, rate or extent of mitochondrion degradation by autophagy.
|
11 |
Q99497 (/NAS)
Q99497 (/NAS)
Q99497 (/NAS)
Q99497 (/NAS)
Q99497 (/NAS)
Q99497 (/NAS)
Q99497 (/NAS)
Q99497 (/NAS)
Q99497 (/NAS)
Q99497 (/NAS)
(1 more) |
Negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway GO:1905259
Any process that stops, prevents or reduces the frequency, rate or extent of intrinsic apoptotic signaling pathway in response to nitrosative stress.
|
11 |
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
(1 more) |
Negative regulation of ubiquitin-specific protease activity GO:2000157
Any process that stops, prevents, or reduces the frequency, rate or extent of ubiquitin-specific protease (deubiquitinase) activity.
|
11 |
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
(1 more) |
Positive regulation of oxidative phosphorylation uncoupler activity GO:2000277
Any process that activates or increases the frequency, rate or extent of oxidative phosphorylation uncoupler activity.
|
11 |
O88767 (/ISS)
Q5E946 (/ISS)
Q5E946 (/ISS)
Q5XJ36 (/ISS)
Q7TQ35 (/ISS)
Q7TQ35 (/ISS)
Q8UW59 (/ISS)
Q95LI9 (/ISS)
Q95LI9 (/ISS)
Q95LI9 (/ISS)
(1 more) |
Positive regulation of transcription regulatory region DNA binding GO:2000679
Any process that activates or increases the frequency, rate or extent of transcription regulatory region DNA binding.
|
11 |
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
(1 more) |
Positive regulation of androgen receptor activity GO:2000825
Any process that activates or increases the frequency, rate or extent of androgen receptor activity.
|
11 |
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
(1 more) |
Negative regulation of extrinsic apoptotic signaling pathway GO:2001237
Any process that stops, prevents or reduces the frequency, rate or extent of extrinsic apoptotic signaling pathway.
|
11 |
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
(1 more) |
Negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway GO:2001268
Any process that stops, prevents or reduces the frequency, rate or extent of cysteine-type endopeptidase activity involved in apoptotic signaling pathway.
|
11 |
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
(1 more) |
Detoxification of copper ion GO:0010273
Any process that reduces or removes the toxicity of copper ion. These include transport of copper away from sensitive areas and to compartments or complexes whose purpose is sequestration of copper ion.
|
10 | O88767 (/ISS) Q5E946 (/ISS) Q5E946 (/ISS) Q7TQ35 (/ISS) Q7TQ35 (/ISS) Q95LI9 (/ISS) Q95LI9 (/ISS) Q95LI9 (/ISS) Q95LI9 (/ISS) Q99LX0 (/ISS) |
Negative regulation of protein binding GO:0032091
Any process that stops, prevents, or reduces the frequency, rate or extent of protein binding.
|
10 | O88767 (/ISS) Q5E946 (/ISS) Q5E946 (/ISS) Q7TQ35 (/ISS) Q7TQ35 (/ISS) Q95LI9 (/ISS) Q95LI9 (/ISS) Q95LI9 (/ISS) Q95LI9 (/ISS) Q99LX0 (/ISS) |
Detoxification of mercury ion GO:0050787
Any process that reduce or remove the toxicity of mercuric ion. These include transport of mercury away from sensitive areas and to compartments or complexes whose purpose is sequestration of mercury ion and/or reduction of mercury ion (Hg
|
10 | O88767 (/ISS) Q5E946 (/ISS) Q5E946 (/ISS) Q7TQ35 (/ISS) Q7TQ35 (/ISS) Q95LI9 (/ISS) Q95LI9 (/ISS) Q95LI9 (/ISS) Q95LI9 (/ISS) Q99LX0 (/ISS) |
Response to oxidative stress GO:0006979
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of oxidative stress, a state often resulting from exposure to high levels of reactive oxygen species, e.g. superoxide anions, hydrogen peroxide (H2O2), and hydroxyl radicals.
|
4 | A1Z9J4 (/IMP) O88767 (/IMP) Q5XJ36 (/IMP) Q9VA37 (/IMP) |
Response to oxidative stress GO:0006979
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of oxidative stress, a state often resulting from exposure to high levels of reactive oxygen species, e.g. superoxide anions, hydrogen peroxide (H2O2), and hydroxyl radicals.
|
2 | A1Z9J4 (/IDA) Q9VA37 (/IDA) |
Adult locomotory behavior GO:0008344
Locomotory behavior in a fully developed and mature organism.
|
2 | Q99LX0 (/IMP) Q9VA37 (/IMP) |
Cellular response to reactive oxygen species GO:0034614
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a reactive oxygen species stimulus. Reactive oxygen species include singlet oxygen, superoxide, and oxygen free radicals.
|
2 | Q99LX0 (/IMP) Q9VA37 (/IMP) |
Negative regulation of neuron death GO:1901215
Any process that stops, prevents or reduces the frequency, rate or extent of neuron death.
|
2 | O16228 (/IGI) P90994 (/IGI) |
Negative regulation of protein phosphorylation GO:0001933
Any process that stops, prevents or reduces the rate of addition of phosphate groups to amino acids within a protein.
|
1 | Q99LX0 (/ISO) |
Negative regulation of protein phosphorylation GO:0001933
Any process that stops, prevents or reduces the rate of addition of phosphate groups to amino acids within a protein.
|
1 | O88767 (/ISS) |
Synaptic transmission, dopaminergic GO:0001963
The vesicular release of dopamine. from a presynapse, across a chemical synapse, the subsequent activation of dopamine receptors at the postsynapse of a target cell (neuron, muscle, or secretory cell) and the effects of this activation on the postsynaptic membrane potential and ionic composition of the postsynaptic cytosol. This process encompasses both spontaneous and evoked release of neurotransmitter and all parts of synaptic vesicle exocytosis. Evoked transmission starts with the arrival of an action potential at the presynapse.
|
1 | Q99LX0 (/IMP) |
Synaptic transmission, dopaminergic GO:0001963
The vesicular release of dopamine. from a presynapse, across a chemical synapse, the subsequent activation of dopamine receptors at the postsynapse of a target cell (neuron, muscle, or secretory cell) and the effects of this activation on the postsynaptic membrane potential and ionic composition of the postsynaptic cytosol. This process encompasses both spontaneous and evoked release of neurotransmitter and all parts of synaptic vesicle exocytosis. Evoked transmission starts with the arrival of an action potential at the presynapse.
|
1 | Q8UW59 (/ISS) |
Positive regulation of acute inflammatory response to antigenic stimulus GO:0002866
Any process that activates or increases the frequency, rate, or extent of an acute inflammatory response to an antigenic stimulus.
|
1 | Q99LX0 (/IMP) |
DNA repair GO:0006281
The process of restoring DNA after damage. Genomes are subject to damage by chemical and physical agents in the environment (e.g. UV and ionizing radiations, chemical mutagens, fungal and bacterial toxins, etc.) and by free radicals or alkylating agents endogenously generated in metabolism. DNA is also damaged because of errors during its replication. A variety of different DNA repair pathways have been reported that include direct reversal, base excision repair, nucleotide excision repair, photoreactivation, bypass, double-strand break repair pathway, and mismatch repair pathway.
|
1 | Q99LX0 (/ISO) |
Negative regulation of protein kinase activity GO:0006469
Any process that stops, prevents, or reduces the frequency, rate or extent of protein kinase activity.
|
1 | Q99LX0 (/ISO) |
Negative regulation of protein kinase activity GO:0006469
Any process that stops, prevents, or reduces the frequency, rate or extent of protein kinase activity.
|
1 | O88767 (/ISS) |
Response to oxidative stress GO:0006979
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of oxidative stress, a state often resulting from exposure to high levels of reactive oxygen species, e.g. superoxide anions, hydrogen peroxide (H2O2), and hydroxyl radicals.
|
1 | Q9VA37 (/IGI) |
Response to oxidative stress GO:0006979
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of oxidative stress, a state often resulting from exposure to high levels of reactive oxygen species, e.g. superoxide anions, hydrogen peroxide (H2O2), and hydroxyl radicals.
|
1 | Q99LX0 (/ISO) |
Mitochondrion organization GO:0007005
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a mitochondrion; includes mitochondrial morphogenesis and distribution, and replication of the mitochondrial genome as well as synthesis of new mitochondrial components.
|
1 | Q99LX0 (/IMP) |
Spermatogenesis GO:0007283
The process of formation of spermatozoa, including spermatocytogenesis and spermiogenesis.
|
1 | O88767 (/IEP) |
Aging GO:0007568
A developmental process that is a deterioration and loss of function over time. Aging includes loss of functions such as resistance to disease, homeostasis, and fertility, as well as wear and tear. Aging includes cellular senescence, but is more inclusive. May precede death and may succeed developmental maturation (GO:0021700).
|
1 | O88767 (/IEP) |
Adult locomotory behavior GO:0008344
Locomotory behavior in a fully developed and mature organism.
|
1 | Q8UW59 (/ISS) |
Larval locomotory behavior GO:0008345
Locomotory behavior in a larval (immature) organism.
|
1 | Q9VA37 (/IMP) |
Fertilization GO:0009566
The union of gametes of opposite sexes during the process of sexual reproduction to form a zygote. It involves the fusion of the gametic nuclei (karyogamy) and cytoplasm (plasmogamy).
|
1 | O88767 (/TAS) |
Response to toxic substance GO:0009636
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a toxic stimulus.
|
1 | P90994 (/IMP) |
Detoxification of copper ion GO:0010273
Any process that reduces or removes the toxicity of copper ion. These include transport of copper away from sensitive areas and to compartments or complexes whose purpose is sequestration of copper ion.
|
1 | Q99LX0 (/ISO) |
Regulation of hydrogen peroxide metabolic process GO:0010310
Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving hydrogen peroxide.
|
1 | Q9VA37 (/IMP) |
Positive regulation of gene expression GO:0010628
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
1 | Q99LX0 (/IMP) |
Negative regulation of gene expression GO:0010629
Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
1 | Q99LX0 (/ISO) |
Phosphatidylinositol 3-kinase signaling GO:0014065
A series of reactions within the signal-receiving cell, mediated by the intracellular phosphatidylinositol 3-kinase (PI3K). Many cell surface receptor linked signaling pathways signal through PI3K to regulate numerous cellular functions.
|
1 | A1Z9J4 (/IGI) |
Phosphatidylinositol 3-kinase signaling GO:0014065
A series of reactions within the signal-receiving cell, mediated by the intracellular phosphatidylinositol 3-kinase (PI3K). Many cell surface receptor linked signaling pathways signal through PI3K to regulate numerous cellular functions.
|
1 | Q9VA37 (/IMP) |
Enzyme active site formation via L-cysteine sulfinic acid GO:0018323
The oxidation of peptidyl-cysteine to form peptidyl-L-cysteine sulfinic acid.
|
1 | Q99LX0 (/IMP) |
Lactate biosynthetic process GO:0019249
The chemical reactions and pathways resulting in the formation of lactate, the anion of lactic acid.
|
1 | Q99LX0 (/ISO) |
Insulin secretion GO:0030073
The regulated release of proinsulin from secretory granules accompanied by cleavage of proinsulin to form mature insulin. In vertebrates, insulin is secreted from B granules in the B cells of the vertebrate pancreas and from insulin-producing cells in insects.
|
1 | Q99LX0 (/IMP) |
Negative regulation of protein ubiquitination GO:0031397
Any process that stops, prevents, or reduces the frequency, rate or extent of the addition of ubiquitin groups to a protein.
|
1 | Q99LX0 (/IMP) |
Negative regulation of protein ubiquitination GO:0031397
Any process that stops, prevents, or reduces the frequency, rate or extent of the addition of ubiquitin groups to a protein.
|
1 | Q99LX0 (/ISO) |
Negative regulation of protein ubiquitination GO:0031397
Any process that stops, prevents, or reduces the frequency, rate or extent of the addition of ubiquitin groups to a protein.
|
1 | O88767 (/ISS) |
Negative regulation of protein binding GO:0032091
Any process that stops, prevents, or reduces the frequency, rate or extent of protein binding.
|
1 | Q99LX0 (/ISO) |
Negative regulation of proteasomal ubiquitin-dependent protein catabolic process GO:0032435
Any process that stops, prevents, or reduces the frequency, rate or extent of the breakdown of a protein or peptide by hydrolysis of its peptide bonds, initiated by the covalent attachment of ubiquitin, and mediated by the proteasome.
|
1 | Q99LX0 (/ISO) |
Positive regulation of interleukin-8 production GO:0032757
Any process that activates or increases the frequency, rate, or extent of interleukin-8 production.
|
1 | Q99LX0 (/ISO) |
Positive regulation of interleukin-8 production GO:0032757
Any process that activates or increases the frequency, rate, or extent of interleukin-8 production.
|
1 | O88767 (/ISS) |
Positive regulation of peptidyl-serine phosphorylation GO:0033138
Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-serine.
|
1 | Q99LX0 (/ISO) |
Negative regulation of protein sumoylation GO:0033234
Any process that stops, prevents, or reduces the frequency, rate or extent of the addition of SUMO groups to a protein.
|
1 | Q99LX0 (/ISO) |
Negative regulation of protein sumoylation GO:0033234
Any process that stops, prevents, or reduces the frequency, rate or extent of the addition of SUMO groups to a protein.
|
1 | O88767 (/ISS) |
Positive regulation of NAD(P)H oxidase activity GO:0033864
Any process that activates or increases the activity of the enzyme NAD(P)H oxidase.
|
1 | Q99LX0 (/IMP) |
Cellular response to oxidative stress GO:0034599
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of oxidative stress, a state often resulting from exposure to high levels of reactive oxygen species, e.g. superoxide anions, hydrogen peroxide (H2O2), and hydroxyl radicals.
|
1 | Q99LX0 (/ISO) |
Cellular response to glyoxal GO:0036471
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glyoxal stimulus.
|
1 | Q99LX0 (/IMP) |
Cellular response to glyoxal GO:0036471
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glyoxal stimulus.
|
1 | Q99LX0 (/ISO) |
Cellular response to glyoxal GO:0036471
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glyoxal stimulus.
|
1 | O88767 (/ISS) |
Peptidyl-cysteine deglycation GO:0036526
The removal of a sugar or dicarbonyl from a cysteine residue of a glycated protein.
|
1 | Q99LX0 (/ISO) |
Peptidyl-arginine deglycation GO:0036527
The removal of a sugar or dicarbonyl from an arginine residue of a glycated protein.
|
1 | Q99LX0 (/ISO) |
Peptidyl-lysine deglycation GO:0036528
The removal of a sugar or dicarbonyl from a lysine residue of a glycated protein.
|
1 | Q99LX0 (/ISO) |
Protein deglycation, glyoxal removal GO:0036529
The removal of glyoxal from a glycated protein, to form glycolate and a deglycated protein.
|
1 | Q99LX0 (/ISO) |
Glutathione deglycation GO:0036531
The removal of a sugar or dicarbonyl from glycated glutathione. Glutathione is the tripeptide glutamylcysteinylglycine.
|
1 | Q99LX0 (/ISO) |
Negative regulation of protein catabolic process GO:0042177
Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of a protein by the destruction of the native, active configuration, with or without the hydrolysis of peptide bonds.
|
1 | Q99LX0 (/IMP) |
Dopamine metabolic process GO:0042417
The chemical reactions and pathways involving dopamine, a catecholamine neurotransmitter and a metabolic precursor of noradrenaline and adrenaline.
|
1 | A1Z9J4 (/IMP) |
Response to drug GO:0042493
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease.
|
1 | O88767 (/IEP) |
Response to hydrogen peroxide GO:0042542
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hydrogen peroxide (H2O2) stimulus.
|
1 | Q99LX0 (/IDA) |
Response to hydrogen peroxide GO:0042542
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hydrogen peroxide (H2O2) stimulus.
|
1 | Q99LX0 (/IMP) |
Response to hydrogen peroxide GO:0042542
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hydrogen peroxide (H2O2) stimulus.
|
1 | Q8UW59 (/ISS) |
Glucose homeostasis GO:0042593
Any process involved in the maintenance of an internal steady state of glucose within an organism or cell.
|
1 | Q99LX0 (/IMP) |
Hydrogen peroxide metabolic process GO:0042743
The chemical reactions and pathways involving hydrogen peroxide (H2O2), a potentially harmful byproduct of aerobic cellular respiration which can cause damage to DNA.
|
1 | Q99LX0 (/IMP) |
Hydrogen peroxide metabolic process GO:0042743
The chemical reactions and pathways involving hydrogen peroxide (H2O2), a potentially harmful byproduct of aerobic cellular respiration which can cause damage to DNA.
|
1 | Q99LX0 (/ISO) |
Hydrogen peroxide metabolic process GO:0042743
The chemical reactions and pathways involving hydrogen peroxide (H2O2), a potentially harmful byproduct of aerobic cellular respiration which can cause damage to DNA.
|
1 | O88767 (/ISS) |
Mitochondrial ATP synthesis coupled electron transport GO:0042775
The transfer of electrons through a series of electron donors and acceptors, generating energy that is ultimately used for synthesis of ATP, as it occurs in the mitochondrial inner membrane or chloroplast thylakoid membrane.
|
1 | A1Z9J4 (/IGI) |
Negative regulation of apoptotic process GO:0043066
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
|
1 | Q99LX0 (/IMP) |
Negative regulation of apoptotic process GO:0043066
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
|
1 | Q99LX0 (/ISO) |
Regulation of neuron apoptotic process GO:0043523
Any process that modulates the occurrence or rate of cell death by apoptotic process in neurons.
|
1 | Q99LX0 (/ISO) |
Negative regulation of neuron apoptotic process GO:0043524
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process in neurons.
|
1 | Q99LX0 (/ISO) |
Negative regulation of neuron apoptotic process GO:0043524
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process in neurons.
|
1 | O88767 (/ISS) |
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
|
1 | Q99LX0 (/ISO) |
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
|
1 | O88767 (/ISS) |
Glycolate biosynthetic process GO:0046295
The chemical reactions and pathways resulting in the formation of glycolate, the anion of hydroxyethanoic acid (glycolic acid).
|
1 | Q99LX0 (/ISO) |
Glycolate biosynthetic process GO:0046295
The chemical reactions and pathways resulting in the formation of glycolate, the anion of hydroxyethanoic acid (glycolic acid).
|
1 | O88767 (/ISS) |
Negative regulation of protein export from nucleus GO:0046826
Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of proteins from the nucleus into the cytoplasm.
|
1 | Q99LX0 (/ISO) |
Negative regulation of protein export from nucleus GO:0046826
Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of proteins from the nucleus into the cytoplasm.
|
1 | O88767 (/ISS) |
Regulation of synaptic plasticity GO:0048167
A process that modulates synaptic plasticity, the ability of synapses to change as circumstances require. They may alter function, such as increasing or decreasing their sensitivity, or they may increase or decrease in actual numbers.
|
1 | Q9VA37 (/IGI) |
Regulation of synaptic plasticity GO:0048167
A process that modulates synaptic plasticity, the ability of synapses to change as circumstances require. They may alter function, such as increasing or decreasing their sensitivity, or they may increase or decrease in actual numbers.
|
1 | Q9VA37 (/IMP) |
Negative regulation of developmental growth GO:0048640
Any process that stops, prevents, or reduces the frequency, rate or extent of developmental growth.
|
1 | Q9VA37 (/IMP) |
Regulation of inflammatory response GO:0050727
Any process that modulates the frequency, rate or extent of the inflammatory response, the immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents.
|
1 | Q99LX0 (/IMP) |
Detoxification of mercury ion GO:0050787
Any process that reduce or remove the toxicity of mercuric ion. These include transport of mercury away from sensitive areas and to compartments or complexes whose purpose is sequestration of mercury ion and/or reduction of mercury ion (Hg
|
1 | Q99LX0 (/ISO) |
Protein stabilization GO:0050821
Any process involved in maintaining the structure and integrity of a protein and preventing it from degradation or aggregation.
|
1 | Q99LX0 (/ISO) |
Positive regulation of DNA-binding transcription factor activity GO:0051091
Any process that activates or increases the frequency, rate or extent of activity of a transcription factor, any factor involved in the initiation or regulation of transcription.
|
1 | Q99LX0 (/ISO) |
Negative regulation of ubiquitin-protein transferase activity GO:0051444
Any process that stops, prevents, or reduces the frequency, rate or extent of ubiquitin transferase activity.
|
1 | Q99LX0 (/IC) |
Negative regulation of ubiquitin-protein transferase activity GO:0051444
Any process that stops, prevents, or reduces the frequency, rate or extent of ubiquitin transferase activity.
|
1 | Q99LX0 (/ISO) |
Dopamine uptake involved in synaptic transmission GO:0051583
The directed movement of dopamine into a presynaptic neuron or glial cell. In this context, dopamine is a catecholamine neurotransmitter and a metabolic precursor of noradrenaline and adrenaline.
|
1 | Q99LX0 (/IMP) |
Dopamine uptake involved in synaptic transmission GO:0051583
The directed movement of dopamine into a presynaptic neuron or glial cell. In this context, dopamine is a catecholamine neurotransmitter and a metabolic precursor of noradrenaline and adrenaline.
|
1 | Q8UW59 (/ISS) |
Regulation of mitochondrial membrane potential GO:0051881
Any process that modulates the establishment or extent of the mitochondrial membrane potential, the electric potential existing across the mitochondrial membrane arising from charges in the membrane itself and from the charges present in the media on either side of the membrane.
|
1 | Q99LX0 (/ISO) |
Regulation of mitochondrial membrane potential GO:0051881
Any process that modulates the establishment or extent of the mitochondrial membrane potential, the electric potential existing across the mitochondrial membrane arising from charges in the membrane itself and from the charges present in the media on either side of the membrane.
|
1 | O88767 (/ISS) |
Regulation of protein kinase B signaling GO:0051896
Any process that modulates the frequency, rate or extent of protein kinase B signaling, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B.
|
1 | A1Z9J4 (/IGI) |
Regulation of protein kinase B signaling GO:0051896
Any process that modulates the frequency, rate or extent of protein kinase B signaling, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B.
|
1 | A1Z9J4 (/IMP) |
Membrane depolarization GO:0051899
The process in which membrane potential decreases with respect to its steady-state potential, usually from negative potential to a more positive potential. For example, the initial depolarization during the rising phase of an action potential is in the direction from the negative steady-state resting potential towards the positive membrane potential that will be the peak of the action potential.
|
1 | Q99LX0 (/IMP) |
Membrane hyperpolarization GO:0060081
The process in which membrane potential increases with respect to its steady-state potential, usually from negative potential to a more negative potential. For example, during the repolarization phase of an action potential the membrane potential often becomes more negative or hyperpolarized before returning to the steady-state resting potential.
|
1 | Q99LX0 (/IMP) |
Maternal process involved in female pregnancy GO:0060135
A reproductive process occurring in the mother that allows an embryo or fetus to develop within it.
|
1 | O88767 (/IEP) |
Negative regulation of cell death GO:0060548
Any process that decreases the rate or frequency of cell death. Cell death is the specific activation or halting of processes within a cell so that its vital functions markedly cease, rather than simply deteriorating gradually over time, which culminates in cell death.
|
1 | Q99LX0 (/IMP) |
Negative regulation of cell death GO:0060548
Any process that decreases the rate or frequency of cell death. Cell death is the specific activation or halting of processes within a cell so that its vital functions markedly cease, rather than simply deteriorating gradually over time, which culminates in cell death.
|
1 | Q99LX0 (/ISO) |
Regulation of androgen receptor signaling pathway GO:0060765
Any process that modulates the rate, frequency, or extent of the androgen receptor signaling pathway.
|
1 | Q99LX0 (/ISO) |
Regulation of androgen receptor signaling pathway GO:0060765
Any process that modulates the rate, frequency, or extent of the androgen receptor signaling pathway.
|
1 | O88767 (/ISS) |
Neuron cellular homeostasis GO:0070050
The cellular homeostatic process that preserves a neuron in a stable, differentiated functional and structural state.
|
1 | A1Z9J4 (/IMP) |
Cellular response to hydrogen peroxide GO:0070301
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hydrogen peroxide (H2O2) stimulus.
|
1 | Q99LX0 (/IMP) |
Cellular response to hydrogen peroxide GO:0070301
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hydrogen peroxide (H2O2) stimulus.
|
1 | Q99LX0 (/ISO) |
Cellular response to lipopolysaccharide GO:0071222
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria.
|
1 | O88767 (/IEP) |
Positive regulation of protein homodimerization activity GO:0090073
Any process that increases the frequency, rate or extent of protein homodimerization, interacting selectively with an identical protein to form a homodimer.
|
1 | Q99LX0 (/ISO) |
Positive regulation of protein homodimerization activity GO:0090073
Any process that increases the frequency, rate or extent of protein homodimerization, interacting selectively with an identical protein to form a homodimer.
|
1 | O88767 (/ISS) |
Cellular response to methylglyoxal GO:0097238
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a methylglyoxal stimulus. Methylglyoxal is a 2-oxoaldehyde derived from propanal.
|
1 | O16228 (/IDA) |
Cellular response to methylglyoxal GO:0097238
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a methylglyoxal stimulus. Methylglyoxal is a 2-oxoaldehyde derived from propanal.
|
1 | P90994 (/IMP) |
Guanine deglycation GO:0106044
The removal of a sugar or dicarbonyl from a glycated guanine.
|
1 | Q99LX0 (/ISO) |
Guanine deglycation, methylglyoxal removal GO:0106045
The removal of methylglyoxal from a glycated guanine, to form lactate and a deglycated guanine.
|
1 | Q99LX0 (/ISO) |
Guanine deglycation, glyoxal removal GO:0106046
The removal of glyoxal from a glycated guanine, to form glycolate and a deglycated guanine.
|
1 | Q99LX0 (/ISO) |
Regulation of neuromuscular synaptic transmission GO:1900073
Any process that modulates the frequency, rate or extent of neuromuscular synaptic transmission.
|
1 | Q9VA37 (/IMP) |
Positive regulation of protein localization to nucleus GO:1900182
Any process that activates or increases the frequency, rate or extent of protein localization to nucleus.
|
1 | Q99LX0 (/ISO) |
Positive regulation of protein localization to nucleus GO:1900182
Any process that activates or increases the frequency, rate or extent of protein localization to nucleus.
|
1 | O88767 (/ISS) |
Negative regulation of neuron death GO:1901215
Any process that stops, prevents or reduces the frequency, rate or extent of neuron death.
|
1 | O88767 (/IMP) |
Negative regulation of neuron death GO:1901215
Any process that stops, prevents or reduces the frequency, rate or extent of neuron death.
|
1 | Q99LX0 (/ISO) |
Positive regulation of superoxide dismutase activity GO:1901671
Any process that activates or increases the frequency, rate or extent of superoxide dismutase activity.
|
1 | Q99LX0 (/ISO) |
Positive regulation of superoxide dismutase activity GO:1901671
Any process that activates or increases the frequency, rate or extent of superoxide dismutase activity.
|
1 | O88767 (/ISS) |
Negative regulation of protein acetylation GO:1901984
Any process that stops, prevents or reduces the frequency, rate or extent of protein acetylation.
|
1 | Q99LX0 (/ISO) |
Negative regulation of protein acetylation GO:1901984
Any process that stops, prevents or reduces the frequency, rate or extent of protein acetylation.
|
1 | O88767 (/ISS) |
Positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway GO:1902177
Any process that activates or increases the frequency, rate or extent of an oxidative stress-induced intrinsic apoptotic signaling pathway.
|
1 | Q99LX0 (/IMP) |
Negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway GO:1902236
Any process that stops, prevents or reduces the frequency, rate or extent of an endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway.
|
1 | Q99LX0 (/IMP) |
Negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway GO:1902236
Any process that stops, prevents or reduces the frequency, rate or extent of an endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway.
|
1 | Q99LX0 (/ISO) |
Positive regulation of mitochondrial electron transport, NADH to ubiquinone GO:1902958
Any process that activates or increases the frequency, rate or extent of mitochondrial electron transport, NADH to ubiquinone.
|
1 | Q99LX0 (/ISO) |
Positive regulation of mitochondrial electron transport, NADH to ubiquinone GO:1902958
Any process that activates or increases the frequency, rate or extent of mitochondrial electron transport, NADH to ubiquinone.
|
1 | O88767 (/ISS) |
Negative regulation of protein K48-linked deubiquitination GO:1903094
Any process that stops, prevents or reduces the frequency, rate or extent of protein K48-linked deubiquitination.
|
1 | Q99LX0 (/ISO) |
Negative regulation of protein K48-linked deubiquitination GO:1903094
Any process that stops, prevents or reduces the frequency, rate or extent of protein K48-linked deubiquitination.
|
1 | O88767 (/ISS) |
Negative regulation of TRAIL-activated apoptotic signaling pathway GO:1903122
Any process that stops, prevents or reduces the frequency, rate or extent of TRAIL-activated apoptotic signaling pathway.
|
1 | Q99LX0 (/ISO) |
Negative regulation of TRAIL-activated apoptotic signaling pathway GO:1903122
Any process that stops, prevents or reduces the frequency, rate or extent of TRAIL-activated apoptotic signaling pathway.
|
1 | O88767 (/ISS) |
Positive regulation of pyrroline-5-carboxylate reductase activity GO:1903168
Any process that activates or increases the frequency, rate or extent of pyrroline-5-carboxylate reductase activity.
|
1 | Q99LX0 (/ISO) |
Positive regulation of pyrroline-5-carboxylate reductase activity GO:1903168
Any process that activates or increases the frequency, rate or extent of pyrroline-5-carboxylate reductase activity.
|
1 | O88767 (/ISS) |
Positive regulation of tyrosine 3-monooxygenase activity GO:1903178
Any process that activates or increases the frequency, rate or extent of tyrosine 3-monooxygenase activity.
|
1 | Q99LX0 (/ISO) |
Positive regulation of tyrosine 3-monooxygenase activity GO:1903178
Any process that activates or increases the frequency, rate or extent of tyrosine 3-monooxygenase activity.
|
1 | O88767 (/ISS) |
Positive regulation of dopamine biosynthetic process GO:1903181
Any process that activates or increases the frequency, rate or extent of dopamine biosynthetic process.
|
1 | Q99LX0 (/ISO) |
Positive regulation of dopamine biosynthetic process GO:1903181
Any process that activates or increases the frequency, rate or extent of dopamine biosynthetic process.
|
1 | O88767 (/ISS) |
Glyoxal metabolic process GO:1903189
The chemical reactions and pathways involving glyoxal.
|
1 | Q99LX0 (/ISO) |
Positive regulation of L-dopa biosynthetic process GO:1903197
Any process that activates or increases the frequency, rate or extent of L-dopa biosynthetic process.
|
1 | Q99LX0 (/ISO) |
Positive regulation of L-dopa biosynthetic process GO:1903197
Any process that activates or increases the frequency, rate or extent of L-dopa biosynthetic process.
|
1 | O88767 (/ISS) |
Positive regulation of L-dopa decarboxylase activity GO:1903200
Any process that activates or increases the frequency, rate or extent of L-dopa decarboxylase activity.
|
1 | Q99LX0 (/ISO) |
Positive regulation of L-dopa decarboxylase activity GO:1903200
Any process that activates or increases the frequency, rate or extent of L-dopa decarboxylase activity.
|
1 | O88767 (/ISS) |
Negative regulation of oxidative stress-induced cell death GO:1903202
Any process that stops, prevents or reduces the frequency, rate or extent of oxidative stress-induced cell death.
|
1 | Q99LX0 (/ISO) |
Negative regulation of oxidative stress-induced neuron death GO:1903204
Any process that stops, prevents or reduces the frequency, rate or extent of oxidative stress-induced neuron death.
|
1 | Q99LX0 (/IMP) |
Negative regulation of hydrogen peroxide-induced cell death GO:1903206
Any process that stops, prevents or reduces the frequency, rate or extent of hydrogen peroxide-induced cell death.
|
1 | Q99LX0 (/ISO) |
Negative regulation of hydrogen peroxide-induced neuron death GO:1903208
Any process that stops, prevents or reduces the frequency, rate or extent of hydrogen peroxide-induced neuron death.
|
1 | Q99LX0 (/IMP) |
Negative regulation of hydrogen peroxide-induced neuron death GO:1903208
Any process that stops, prevents or reduces the frequency, rate or extent of hydrogen peroxide-induced neuron death.
|
1 | Q99LX0 (/ISO) |
Negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway GO:1903377
Any process that stops, prevents or reduces the frequency, rate or extent of oxidative stress-induced neuron intrinsic apoptotic signaling pathway.
|
1 | Q99LX0 (/ISO) |
Negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway GO:1903377
Any process that stops, prevents or reduces the frequency, rate or extent of oxidative stress-induced neuron intrinsic apoptotic signaling pathway.
|
1 | O88767 (/ISS) |
Negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway GO:1903384
Any process that stops, prevents or reduces the frequency, rate or extent of a hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway.
|
1 | Q99LX0 (/IMP) |
Negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway GO:1903384
Any process that stops, prevents or reduces the frequency, rate or extent of a hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway.
|
1 | Q99LX0 (/ISO) |
Negative regulation of reactive oxygen species biosynthetic process GO:1903427
Any process that stops, prevents or reduces the frequency, rate or extent of reactive oxygen species biosynthetic process.
|
1 | Q99LX0 (/IMP) |
Positive regulation of reactive oxygen species biosynthetic process GO:1903428
Any process that activates or increases the frequency, rate or extent of reactive oxygen species biosynthetic process.
|
1 | Q99LX0 (/IDA) |
Negative regulation of NMDA glutamate receptor activity GO:1904782
Any process that stops, prevents or reduces the frequency, rate or extent of NMDA glutamate receptor activity.
|
1 | O88767 (/IMP) |
Negative regulation of NMDA glutamate receptor activity GO:1904782
Any process that stops, prevents or reduces the frequency, rate or extent of NMDA glutamate receptor activity.
|
1 | Q99LX0 (/ISO) |
Negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway GO:1905259
Any process that stops, prevents or reduces the frequency, rate or extent of intrinsic apoptotic signaling pathway in response to nitrosative stress.
|
1 | Q99LX0 (/ISO) |
Regulation of mitochondrial ATP synthesis coupled electron transport GO:1905446
Any process that modulates the frequency, rate or extent of mitochondrial ATP synthesis coupled electron transport.
|
1 | Q9VA37 (/IGI) |
Positive regulation of fertilization GO:1905516
Any process that activates or increases the frequency, rate or extent of fertilization.
|
1 | O88767 (/IMP) |
Positive regulation of fertilization GO:1905516
Any process that activates or increases the frequency, rate or extent of fertilization.
|
1 | Q99LX0 (/ISO) |
Negative regulation of ubiquitin-specific protease activity GO:2000157
Any process that stops, prevents, or reduces the frequency, rate or extent of ubiquitin-specific protease (deubiquitinase) activity.
|
1 | Q99LX0 (/ISO) |
Negative regulation of ubiquitin-specific protease activity GO:2000157
Any process that stops, prevents, or reduces the frequency, rate or extent of ubiquitin-specific protease (deubiquitinase) activity.
|
1 | O88767 (/ISS) |
Positive regulation of oxidative phosphorylation uncoupler activity GO:2000277
Any process that activates or increases the frequency, rate or extent of oxidative phosphorylation uncoupler activity.
|
1 | Q99LX0 (/IMP) |
Positive regulation of transcription regulatory region DNA binding GO:2000679
Any process that activates or increases the frequency, rate or extent of transcription regulatory region DNA binding.
|
1 | Q99LX0 (/ISO) |
Positive regulation of androgen receptor activity GO:2000825
Any process that activates or increases the frequency, rate or extent of androgen receptor activity.
|
1 | Q99LX0 (/ISO) |
Positive regulation of androgen receptor activity GO:2000825
Any process that activates or increases the frequency, rate or extent of androgen receptor activity.
|
1 | O88767 (/ISS) |
Negative regulation of extrinsic apoptotic signaling pathway GO:2001237
Any process that stops, prevents or reduces the frequency, rate or extent of extrinsic apoptotic signaling pathway.
|
1 | Q99LX0 (/ISO) |
Negative regulation of extrinsic apoptotic signaling pathway GO:2001237
Any process that stops, prevents or reduces the frequency, rate or extent of extrinsic apoptotic signaling pathway.
|
1 | O88767 (/ISS) |
Negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway GO:2001268
Any process that stops, prevents or reduces the frequency, rate or extent of cysteine-type endopeptidase activity involved in apoptotic signaling pathway.
|
1 | Q99LX0 (/ISO) |
Negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway GO:2001268
Any process that stops, prevents or reduces the frequency, rate or extent of cysteine-type endopeptidase activity involved in apoptotic signaling pathway.
|
1 | O88767 (/ISS) |
There are 39 GO terms relating to "cellular component"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
|
26 |
K7EN27 (/IDA)
O88767 (/IDA)
P90994 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
(16 more) |
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
|
25 |
K7EN27 (/IDA)
O88767 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
(15 more) |
Mitochondrion GO:0005739
A semiautonomous, self replicating organelle that occurs in varying numbers, shapes, and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration.
|
14 |
A1Z9J4 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
(4 more) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
13 |
O16228 (/IDA)
P90994 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
(3 more) |
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
|
12 |
O88767 (/ISS)
Q5E946 (/ISS)
Q5E946 (/ISS)
Q5XJ36 (/ISS)
Q7TQ35 (/ISS)
Q7TQ35 (/ISS)
Q8UW59 (/ISS)
Q95LI9 (/ISS)
Q95LI9 (/ISS)
Q95LI9 (/ISS)
(2 more) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
12 |
O88767 (/ISS)
Q5E946 (/ISS)
Q5E946 (/ISS)
Q5XJ36 (/ISS)
Q7TQ35 (/ISS)
Q7TQ35 (/ISS)
Q8UW59 (/ISS)
Q95LI9 (/ISS)
Q95LI9 (/ISS)
Q95LI9 (/ISS)
(2 more) |
Chromatin GO:0000785
The ordered and organized complex of DNA, protein, and sometimes RNA, that forms the chromosome.
|
11 |
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
(1 more) |
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
|
11 |
Q99497 (/HDA)
Q99497 (/HDA)
Q99497 (/HDA)
Q99497 (/HDA)
Q99497 (/HDA)
Q99497 (/HDA)
Q99497 (/HDA)
Q99497 (/HDA)
Q99497 (/HDA)
Q99497 (/HDA)
(1 more) |
Nucleoplasm GO:0005654
That part of the nuclear content other than the chromosomes or the nucleolus.
|
11 |
Q99497 (/TAS)
Q99497 (/TAS)
Q99497 (/TAS)
Q99497 (/TAS)
Q99497 (/TAS)
Q99497 (/TAS)
Q99497 (/TAS)
Q99497 (/TAS)
Q99497 (/TAS)
Q99497 (/TAS)
(1 more) |
Mitochondrion GO:0005739
A semiautonomous, self replicating organelle that occurs in varying numbers, shapes, and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration.
|
11 |
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
(1 more) |
Mitochondrion GO:0005739
A semiautonomous, self replicating organelle that occurs in varying numbers, shapes, and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration.
|
11 |
O88767 (/ISS)
Q5E946 (/ISS)
Q5E946 (/ISS)
Q5XJ36 (/ISS)
Q7TQ35 (/ISS)
Q7TQ35 (/ISS)
Q8UW59 (/ISS)
Q95LI9 (/ISS)
Q95LI9 (/ISS)
Q95LI9 (/ISS)
(1 more) |
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
|
11 |
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
Q99497 (/IMP)
(1 more) |
Cell-cell adherens junction GO:0005913
An adherens junction which connects a cell to another cell.
|
11 |
Q99497 (/HDA)
Q99497 (/HDA)
Q99497 (/HDA)
Q99497 (/HDA)
Q99497 (/HDA)
Q99497 (/HDA)
Q99497 (/HDA)
Q99497 (/HDA)
Q99497 (/HDA)
Q99497 (/HDA)
(1 more) |
PML body GO:0016605
A class of nuclear body; they react against SP100 auto-antibodies (PML, promyelocytic leukemia); cells typically contain 10-30 PML bodies per nucleus; alterations in the localization of PML bodies occurs after viral infection.
|
11 |
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
(1 more) |
Axon GO:0030424
The long process of a neuron that conducts nerve impulses, usually away from the cell body to the terminals and varicosities, which are sites of storage and release of neurotransmitter.
|
11 |
Q99497 (/ISS)
Q99497 (/ISS)
Q99497 (/ISS)
Q99497 (/ISS)
Q99497 (/ISS)
Q99497 (/ISS)
Q99497 (/ISS)
Q99497 (/ISS)
Q99497 (/ISS)
Q99497 (/ISS)
(1 more) |
Perinuclear region of cytoplasm GO:0048471
Cytoplasm situated near, or occurring around, the nucleus.
|
11 |
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
Q99497 (/IDA)
(1 more) |
Extracellular exosome GO:0070062
A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
|
11 |
Q99497 (/HDA)
Q99497 (/HDA)
Q99497 (/HDA)
Q99497 (/HDA)
Q99497 (/HDA)
Q99497 (/HDA)
Q99497 (/HDA)
Q99497 (/HDA)
Q99497 (/HDA)
Q99497 (/HDA)
(1 more) |
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
|
8 | Q5E946 (/ISS) Q5E946 (/ISS) Q7TQ35 (/ISS) Q7TQ35 (/ISS) Q95LI9 (/ISS) Q95LI9 (/ISS) Q95LI9 (/ISS) Q95LI9 (/ISS) |
Chromatin GO:0000785
The ordered and organized complex of DNA, protein, and sometimes RNA, that forms the chromosome.
|
1 | Q99LX0 (/ISO) |
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
|
1 | Q99LX0 (/ISO) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
1 | Q99LX0 (/ISO) |
Mitochondrion GO:0005739
A semiautonomous, self replicating organelle that occurs in varying numbers, shapes, and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration.
|
1 | Q99LX0 (/HDA) |
Mitochondrion GO:0005739
A semiautonomous, self replicating organelle that occurs in varying numbers, shapes, and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration.
|
1 | Q99LX0 (/ISO) |
Mitochondrial intermembrane space GO:0005758
The region between the inner and outer lipid bilayers of the mitochondrial envelope.
|
1 | Q99LX0 (/IDA) |
Mitochondrial matrix GO:0005759
The gel-like material, with considerable fine structure, that lies in the matrix space, or lumen, of a mitochondrion. It contains the enzymes of the tricarboxylic acid cycle and, in some organisms, the enzymes concerned with fatty acid oxidation.
|
1 | Q99LX0 (/IDA) |
Endoplasmic reticulum GO:0005783
The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached).
|
1 | Q99LX0 (/IDA) |
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
|
1 | Q99LX0 (/ISO) |
PML body GO:0016605
A class of nuclear body; they react against SP100 auto-antibodies (PML, promyelocytic leukemia); cells typically contain 10-30 PML bodies per nucleus; alterations in the localization of PML bodies occurs after viral infection.
|
1 | Q99LX0 (/ISO) |
PML body GO:0016605
A class of nuclear body; they react against SP100 auto-antibodies (PML, promyelocytic leukemia); cells typically contain 10-30 PML bodies per nucleus; alterations in the localization of PML bodies occurs after viral infection.
|
1 | O88767 (/ISS) |
Axon GO:0030424
The long process of a neuron that conducts nerve impulses, usually away from the cell body to the terminals and varicosities, which are sites of storage and release of neurotransmitter.
|
1 | O88767 (/IDA) |
Axon GO:0030424
The long process of a neuron that conducts nerve impulses, usually away from the cell body to the terminals and varicosities, which are sites of storage and release of neurotransmitter.
|
1 | Q99LX0 (/ISO) |
Neuron projection GO:0043005
A prolongation or process extending from a nerve cell, e.g. an axon or dendrite.
|
1 | Q99LX0 (/IDA) |
Cell body GO:0044297
The portion of a cell bearing surface projections such as axons, dendrites, cilia, or flagella that includes the nucleus, but excludes all cell projections.
|
1 | Q99LX0 (/IDA) |
Membrane raft GO:0045121
Any of the small (10-200 nm), heterogeneous, highly dynamic, sterol- and sphingolipid-enriched membrane domains that compartmentalize cellular processes. Small rafts can sometimes be stabilized to form larger platforms through protein-protein and protein-lipid interactions.
|
1 | O88767 (/IDA) |
Membrane raft GO:0045121
Any of the small (10-200 nm), heterogeneous, highly dynamic, sterol- and sphingolipid-enriched membrane domains that compartmentalize cellular processes. Small rafts can sometimes be stabilized to form larger platforms through protein-protein and protein-lipid interactions.
|
1 | Q99LX0 (/ISO) |
Perinuclear region of cytoplasm GO:0048471
Cytoplasm situated near, or occurring around, the nucleus.
|
1 | Q99LX0 (/ISO) |
Sperm head GO:0061827
The part of the late spermatid or spermatozoon that contains the nucleus and acrosome.
|
1 | O88767 (/IDA) |
Sperm head GO:0061827
The part of the late spermatid or spermatozoon that contains the nucleus and acrosome.
|
1 | Q99LX0 (/ISO) |
Extracellular exosome GO:0070062
A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
|
1 | O88767 (/ISS) |